Aerska
EF 2025 · Developing RNA medicines to treat, delay, and prevent diseases of the brain.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YC +1W20 | |
| AI | Not stated | EF2024 | |
| Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | EF2025 | |
| Other | Not stated | EF2019 | |
| Other | Not stated | EF2022 | |
| AI | Active | YCS21 | |
| Other | Not stated | EF2024 |
Also from EF
All of EFPrograms
| Program | Cohort | Source |
|---|---|---|
| 2025 | EF Page |
About Aerska
- Category
- Other
- Location
- External
- Checked
- 1h ago
Tags: Biotechnology, Healthcare
Aerska: questions
Which accelerators did Aerska go through?
Aerska is listed by Entrepreneur First (2025).
Where is Aerska based?
Aerska lists External as its location on Entrepreneur First's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.